Ligand validation:1HT8

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 1HT8 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1HT8_NAG_B_2671	55%	47%	0.153	0.935	1.04	0.99	1	-	5	0	93%	0.9333
1HT8_NAG_A_1671	55%	54%	0.151	0.931	0.88	0.91	1	-	6	0	93%	0.9333
1HT8_NAG_A_1672	14%	38%	0.266	0.832	1.32	1.1	3	2	1	0	93%	0.9333
1HT8_NAG_B_2672	14%	41%	0.253	0.818	1.2	1.08	2	1	1	0	93%	0.9333
1HT8_NAG_A_1661	8%	35%	0.288	0.781	1.5	1.09	3	1	2	0	93%	0.9333
1HT8_NAG_B_2661	8%	36%	0.288	0.77	1.43	1.09	2	1	2	0	93%	0.9333
1HT8_NAG_A_1681	4%	30%	0.354	0.728	1.51	1.28	4	2	2	0	93%	0.9333
1HT8_NAG_B_2681	3%	35%	0.328	0.676	1.44	1.11	4	1	2	0	93%	0.9333
1EBV_NAG_A_681	97%	61%	0.07	0.986	0.49	0.98	-	1	3	0	100%	0.9333
1HT5_NAG_B_2671	75%	49%	0.12	0.964	1.08	0.91	1	1	4	0	93%	0.9333
1PGF_NAG_A_681	71%	58%	0.113	0.933	0.77	0.85	-	1	0	0	100%	0.9333
1EQG_NAG_A_671	59%	64%	0.144	0.939	0.69	0.69	-	-	3	0	93%	0.9333
1PGE_NAG_B_681	56%	56%	0.126	0.896	0.51	1.17	-	2	0	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5F9W_NAG_A_510	100%	88%	0.023	0.994	0.24	0.43	-	-	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.